Your browser doesn't support javascript.
loading
Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials.
Hanauer, Stephen; Sandborn, William J; Colombel, Jean-Frederic; Vermeire, Severine; Petersson, Joel; Kligys, Kristina; Zhou, Qian; Lazar, Andreas; Reinisch, Walter.
Afiliação
  • Hanauer S; Northwestern University, Digestive Health Centre, Chicago, IL, USA.
  • Sandborn WJ; University of California San Diego, Division of Gastroenterology, La Jolla, CA, USA.
  • Colombel JF; Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, NY, USA.
  • Vermeire S; University Hospital Leuven, Gastroenterology, Leuven, Belgium.
  • Petersson J; AbbVie Inc., Global Pharmaceutical Research & Development, North Chicago, IL, USA.
  • Kligys K; AbbVie Inc., Global Pharmaceutical Research & Development, North Chicago, IL, USA.
  • Zhou Q; AbbVie Inc., Global Pharmaceutical Research & Development, North Chicago, IL, USA.
  • Lazar A; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.
  • Reinisch W; Medical University of Vienna, Department for Gastroenterology and Hepatology, Vienna, Austria.
J Crohns Colitis ; 13(9): 1227-1233, 2019 Sep 19.
Article em En | MEDLINE | ID: mdl-30726897

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Adalimumab / Anti-Inflamatórios Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Adalimumab / Anti-Inflamatórios Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos